Redmile Group, LLC
Source: SEC Form 13F · as of Mar 2026Redmile Group, LLC holds 17 biotech & pharma companies tracked by BioSniper, totaling $183.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$183.6M
| Company | Shares | Value |
|---|---|---|
| BEAMBeam Therapeutics Inc. | 1,237,659 | $29.5M |
| COGTCogent Biosciences, Inc. | 688,036 | $26.5M |
| IDYAIDEAYA Biosciences, Inc. | 521,117 | $17.4M |
| XENEXenon Pharmaceuticals Inc. | 262,674 | $15.3M |
| SLDBSolid Biosciences Inc. | 2,011,895 | $14.5M |
| NUVBNuvation Bio Inc. | 3,153,256 | $13.5M |
| ZYMEZymeworks Inc. | 491,654 | $12.3M |
| DBVTDBV Technologies S.A. | 491,340 | $10.3M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 173,859 | $9.8M |
| CLDXCelldex Therapeutics, Inc. | 261,508 | $8.3M |
| PRMEPrime Medicine, Inc. | 1,590,832 | $5.5M |
| ORICOric Pharmaceuticals, Inc. | 415,710 | $5.3M |
| EPRXEUPRAXIA PHARMACEUTICALS INC. | 700,000 | $5.1M |
| ARDXARDELYX, INC. | 733,350 | $4.4M |
| IVVDInvivyd, Inc. | 2,648,659 | $3.4M |
| AGMBAgomAb Therapeutics NV | 156,250 | $1.6M |
| PLRXPLIANT THERAPEUTICS, INC. | 772,126 | $973K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.